Healthcare provider profile · identity verified

Martin Van Cleeff, MD

Internal Medicine · CARY, NC · NPI 1306985494

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	538	125
Rosuvastatin Calcium	Rosuvastatin Calcium	512	144
Amlodipine Besylate	Amlodipine Besylate	220	62
Omeprazole	Omeprazole	211	59
Metoprolol Succinate	Metoprolol Succinate	184	46
Atorvastatin Calcium	Atorvastatin Calcium	131	33
Pantoprazole Sodium	Pantoprazole Sodium	121	30
Eliquis	Apixaban	114	28
Tamsulosin Hcl	Tamsulosin Hcl	113	33
Meloxicam	Meloxicam	105	38
Synthroid	Levothyroxine Sodium	104	26
Losartan Potassium	Losartan Potassium	103	26
Ezetimibe	Ezetimibe	93	27
Lisinopril	Lisinopril	91	24
Alprazolam	Alprazolam	84	35
Gabapentin	Gabapentin	82	28
Zolpidem Tartrate	Zolpidem Tartrate	81	29
Azithromycin	Azithromycin	77	67
Hydrochlorothiazide	Hydrochlorothiazide	75	24
Escitalopram Oxalate	Escitalopram Oxalate	73	21
Glimepiride	Glimepiride	72	18
Furosemide	Furosemide	71	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	68	16
Sertraline Hcl	Sertraline Hcl	67	17
Methylprednisolone	Methylprednisolone	66	53
Bupropion Xl	Bupropion Hcl	65	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	65	50
Carvedilol	Carvedilol	64	17
Simvastatin	Simvastatin	64	15
Clopidogrel	Clopidogrel Bisulfate	62	15
Citalopram Hbr	Citalopram Hydrobromide	60	12
Temazepam	Temazepam	53	16
Fluticasone Propionate	Fluticasone Propionate	51	17
Prednisone	Prednisone	50	18
Ondansetron Odt	Ondansetron	49	28
Amitriptyline Hcl	Amitriptyline Hcl	46	11
Jardiance	Empagliflozin	45	suppressed
Pravastatin Sodium	Pravastatin Sodium	44	11
Tramadol Hcl	Tramadol Hcl	44	14
Montelukast Sodium	Montelukast Sodium	43	13
Trazodone Hcl	Trazodone Hcl	43	13
Metformin Hcl Er	Metformin Hcl	41	suppressed
Spironolactone	Spironolactone	40	11
Irbesartan	Irbesartan	39	suppressed
Rivastigmine	Rivastigmine	39	suppressed
Clonazepam	Clonazepam	37	13
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	35	12
Finasteride	Finasteride	34	suppressed
Ibandronate Sodium	Ibandronate Sodium	34	suppressed
Allopurinol	Allopurinol	33	suppressed
Cefdinir	Cefdinir	33	26
Pioglitazone Hcl	Pioglitazone Hcl	33	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	32	15
Donepezil Hcl	Donepezil Hcl	32	suppressed
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Famotidine	Famotidine	32	suppressed
Ramipril	Ramipril	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Potassium Chloride	Potassium Chloride	29	suppressed
Repatha Sureclick	Evolocumab	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	21
Buspirone Hcl	Buspirone Hcl	26	suppressed
Ipratropium Bromide	Ipratropium Bromide	26	15
Metformin Hcl	Metformin Hcl	26	suppressed
Mometasone Furoate	Mometasone Furoate	26	18
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	13
Paxlovid	Nirmatrelvir/Ritonavir	24	23
Valacyclovir	Valacyclovir Hcl	24	12
Vitamin D2	Ergocalciferol (Vitamin D2)	23	suppressed
Estradiol	Estradiol	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Telmisartan	Telmisartan	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Rizatriptan	Rizatriptan Benzoate	19	suppressed
Fluconazole	Fluconazole	18	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	12
Xarelto	Rivaroxaban	18	suppressed
Flecainide Acetate	Flecainide Acetate	17	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	17	suppressed
Liothyronine Sodium	Liothyronine Sodium	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	12
Dutasteride	Dutasteride	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Testosterone	Testosterone	15	suppressed
Lovastatin	Lovastatin	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Novolog	Insulin Aspart	13	suppressed
Primidone	Primidone	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Moxifloxacin Hcl	Moxifloxacin Hcl	12	12
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Torsemide	Torsemide	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Diclofenac Potassium	Diclofenac Potassium	11	suppressed
Dutasteride-Tamsulosin	Dutasteride/Tamsulosin Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	11	11
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error